Rhythm Pharmaceuticals Inc banner

Multiples-Based Value

The Multiples-Based Value for Rhythm Pharmaceuticals Inc (RYTM) under the Base Case is 50.278 USD. Compared with the current market price of 84.295 USD, the stock appears Overvalued by 40% .

Multiples-Based Value is the estimated value of a stock based on various valuation multiples like P/E and EV/EBIT ratios. It offers a quick snapshot of a stock's valuation in relation to its peers and historical norms.

RYTM Multiples-Based Value
Base Case
$50.278
Overvaluation 40%
Multiples-Based Value
Price $84.295

Multiples Across Competitors

RYTM Competitors Multiples
Rhythm Pharmaceuticals Inc Competitors